Patents by Inventor Richard W. Scott

Richard W. Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Minimally invasive implantable neurostimulation system
    Patent number: 11957893
    Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: April 16, 2024
    Assignee: Medtronic, Inc.
    Inventors: Brad C. Tischendorf, John E. Kast, Thomas P. Miltich, Gordon O. Munns, Randy S. Roles, Craig L. Schmidt, Joseph J. Viavattine, Christian S. Nielsen, Prabhakar A. Tamirisa, Anthony M. Chasensky, Markus W. Reiterer, Chris J. Paidosh, Reginald D. Robinson, Bernard Q. Li, Erik R. Scott, Phillip C. Falkner, Xuan K. Wei, Eric H. Bonde, David A. Dinsmoor, Duane L. Bourget, Forrest C M Pape, Gabriela C. Molnar, Joel A. Anderson, Michael J. Ebert, Richard T. Stone, Shawn C. Kelley, Stephen J. Roddy, Timothy J. Denison, Todd V. Smith
  • Minimally invasive implantable neurostimulation system
    Patent number: 11957894
    Abstract: A neuromodulation therapy is delivered via at least one electrode implanted subcutaneously and superficially to a fascia layer superficial to a nerve of a patient. In one example, an implantable medical device is deployed along a superficial surface of a deep fascia tissue layer superficial to a nerve of a patient. Electrical stimulation energy is delivered to the nerve through the deep fascia tissue layer via implantable medical device electrodes.
    Type: Grant
    Filed: August 25, 2020
    Date of Patent: April 16, 2024
    Assignee: Medtronic, Inc.
    Inventors: Anthony M. Chasensky, Bernard Q. Li, Brad C. Tischendorf, Chris J. Paidosh, Christian S. Nielsen, Craig L. Schmidt, David A. Dinsmoor, Duane L. Bourget, Eric H. Bonde, Erik R. Scott, Forrest C M Pape, Gabriela C. Molnar, Gordon O. Munns, Joel A. Anderson, John E. Kast, Joseph J. Viavattine, Markus W. Reiterer, Michael J. Ebert, Phillip C. Falkner, Prabhakar A. Tamirisa, Randy S. Roles, Reginald D. Robinson, Richard T. Stone, Shawn C. Kelley, Stephen J. Roddy, Thomas P. Miltich, Timothy J. Denison, Todd V. Smith, Xuan K. Wei
  • NOVEL HETEROAROMATIC COMPOUNDS EXHIBITING ANTIFUNGAL ACTIVITY AND THEIR METHOD OF USE
    Publication number: 20240018121
    Abstract: Pharmaceutical compositions include heteroaromatic compounds having a disease-modifying action in the treatment of fungal infections and diseases associated with fungal infection.
    Type: Application
    Filed: June 3, 2021
    Publication date: January 18, 2024
    Applicant: FOX CHASE CHEMCIAL DIVERSITY CENTER, INC.
    Inventors: Simon David Peter BAUGH, Kathryn B. FREEMAN, Jeffrey Claude PELLETIER, Allen B. REITZ, Richard W. SCOTT, Garry Robert SMITH, Sandeep THANNA, Damian G. WEAVER, David B. WHITMAN
  • Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis
    Publication number: 20230235301
    Abstract: The present disclosure relates generally to stapled peptides, and pharmaceutical compositions thereof, which are useful for preventing and/or treating herpes simplex virus-1 (HSV-1) processive DNA synthesis, propagation, and/or infection in a subject.
    Type: Application
    Filed: June 3, 2021
    Publication date: July 27, 2023
    Inventors: Robert P. Ricciardi, Manunya Nuth, Hancheng Guan, Richard W. Scott, Michael H. Parker, Allen B. Reitz
  • Arylamide compounds and compositions and uses thereof
    Publication number: 20210093636
    Abstract: The present invention discloses ophthalmic and otic compositions of facially amphiphilic antimicrobial polymers and oligomers and their uses, including their use in methods for treating and preventing ophthalmic infections and otic infections in humans and animals.
    Type: Application
    Filed: October 28, 2020
    Publication date: April 1, 2021
    Inventor: Richard W. Scott
  • Compounds for use in treatment of mucositis
    Patent number: 10603294
    Abstract: The present invention provides methods for treating and/or preventing mucostitis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: March 31, 2020
    Assignee: Innovation Pharmaceuticals Inc.
    Inventors: Richard W. Scott, Bozena Korczak
  • Arylamide compounds and compositions and uses thereof
    Publication number: 20190314370
    Abstract: The present invention discloses ophthalmic and otic compositions of facially amphiphilic antimicrobial polymers and oligomers and their uses, including their use in methods for treating and preventing ophthalmic infections and otic infections in humans and animals.
    Type: Application
    Filed: November 13, 2018
    Publication date: October 17, 2019
    Inventor: Richard W. Scott
  • Compounds For Use In Treatment Of Mucositis
    Publication number: 20190282521
    Abstract: The present invention provides methods for treating and/or preventing mucostitis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Application
    Filed: January 15, 2019
    Publication date: September 19, 2019
    Inventors: Richard W. Scott, Bozena Korczak
  • Compounds for use in treatment of mucositis
    Patent number: 10206894
    Abstract: The present invention provides methods for treating and/or preventing mucositis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: February 19, 2019
    Assignee: Innovation Pharmaceuticals Inc.
    Inventors: Richard W. Scott, Bozena Korczak
  • Arylamide compounds and compositions and uses thereof
    Patent number: 10166232
    Abstract: The present invention discloses ophthalmic and otic compositions of facially amphiphilic antimicrobial polymers and oligomers and their uses, including their use in methods for treating and preventing ophthalmic infections and otic infections in humans and animals.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: January 1, 2019
    Assignee: Innovation Pharmaceuticals Inc.
    Inventor: Richard W. Scott
  • Compounds For Use In Treatment of Mucositis
    Publication number: 20180064664
    Abstract: The present invention provides methods for treating and/or preventing mucositis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Application
    Filed: September 12, 2017
    Publication date: March 8, 2018
    Inventors: Richard W. Scott, Bozena Korczak
  • Compounds for use in treatment of mucositis
    Patent number: 9795575
    Abstract: The present invention provides methods for treating and/or preventing mucositis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: October 24, 2017
    Assignee: Innovation Pharmaceuticals Inc.
    Inventors: Richard W. Scott, Bozena Korczak
  • Compounds For Use In Treatment Of Mucositis
    Publication number: 20170224640
    Abstract: The present invention provides methods for treating and/or preventing mucostitis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Application
    Filed: August 17, 2016
    Publication date: August 10, 2017
    Inventors: Richard W. Scott, Bozena Korczak
  • Cyclic compounds and methods of making and using the same
    Patent number: 9469616
    Abstract: The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: October 18, 2016
    Assignees: Cellceutix Corporation, University of Massachusetts
    Inventors: Yan Li, Hitesh Thaker, Gregory N. Tew, Dahui Liu, Wenxi Pan, Richard W Scott, Xiaodong Fan
  • COMPOUNDS AND METHODS FOR TREATING CANDIDIASIS AND ASPERGILLUS INFECTIONS
    Publication number: 20160287586
    Abstract: The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for killing or inhibiting the growth of a Candida or Aspergillus species or preventing or treating a mammal having candidiasis (oral and/or disseminated) or an Aspergillus infection.
    Type: Application
    Filed: November 7, 2014
    Publication date: October 6, 2016
    Inventors: Richard W. Scott, Kathryn B. Freeman, Haizhong Tang, Gill Diamond
  • Compounds for use in treatment of mucostis
    Patent number: 9457027
    Abstract: The present invention provides methods for treating and/or preventing mucostitis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: October 4, 2016
    Assignee: Cellceutix Corporation
    Inventors: Richard W. Scott, Bozena Korczak
  • Arylamide compounds and compositions and uses thereof
    Publication number: 20160228435
    Abstract: The present invention discloses ophthalmic and otic compositions of facially amphiphilic antimicrobial polymers and oligomers and their uses, including their use in methods for treating and preventing ophthalmic infections and otic infections in humans and animals.
    Type: Application
    Filed: October 9, 2015
    Publication date: August 11, 2016
    Inventor: Richard W. Scott
  • Compounds for use in Treatment of Mucostis
    Publication number: 20160213668
    Abstract: The present invention provides methods for treating and/or preventing mucostitis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Application
    Filed: August 26, 2015
    Publication date: July 28, 2016
    Inventors: Richard W. Scott, Bozena Korczak
  • Arylamide compounds and compositions and uses thereof
    Patent number: 9192623
    Abstract: The present invention discloses ophthalmic and otic compositions of facially amphiphilic antimicrobial polymers and oligomers and their uses, including their use in methods for treating and preventing ophthalmic infections and otic infections in humans and animals.
    Type: Grant
    Filed: October 26, 2012
    Date of Patent: November 24, 2015
    Assignee: Cellceutix Corporation
    Inventor: Richard W. Scott
  • Compounds for use in treatment of mucostitis
    Patent number: 9155738
    Abstract: The present invention provides methods for treating and/or preventing mucostitis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: October 13, 2015
    Assignee: Cellceutix Corporation
    Inventors: Richard W. Scott, Bozena Korczak